Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Petrol Diesel Prices
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / DRDO's anti-coronavirus drug cleared for emergency use by DCGI
India

DRDO's anti-coronavirus drug cleared for emergency use by DCGI

DRDO's anti-coronavirus drug cleared for emergency use by DCGI
Written by Sagar
May 08, 2021, 05:45 pm 3 min read
DRDO's anti-coronavirus drug cleared for emergency use by DCGI

The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-coronavirus drug developed by a laboratory of the Defence Research and Development Organisation (DRDO) to treat moderate to severe patients, reports say. The drug can help save precious lives even as a dreadful second wave of the coronavirus continues to kill thousands every day. Here are more details on this.

Details
Drug comes in powder form, can be consumed orally

The Institute of Nuclear Medicine and Allied Sciences (INMAS), the DRDO lab, along with the Hyderabad-based Dr. Reddy's Laboratories, has developed the anti-coronavirus therapeutic application of the drug 2-Deoxy-D-Glucose, also called 2-DG. The medicine comes in powder form in a sachet and can be consumed orally by dissolving it in water, the government has said in a release.

Details
It helps in faster recovery of patients, says government

The results of clinical trials for the drug show that a molecule present in it helps in faster recovery of hospitalized coronavirus patients and also reduces their dependence on supplemental oxygen. It accumulates in the infected cells and stops the fatal virus from multiplying. In fact, a high percentage of patients treated with the drug tested negative for coronavirus in RT-PCR tests.

Trials
Work on the drug was started early last year

Scientists at INMAS-DRDO had started experimenting with this drug early last year. In the second round of trials, conducted on 110 patients, the drug was found to be safe for use in COVID-19 patients and showed significant improvement in their recovery process. Thereafter, phase three trials were conducted on 220 patients from last December to March 2021 at 27 coronavirus hospitals in several states.

Crisis
The COVID-19 crisis in India

India is facing an unprecedented second wave of the coronavirus pandemic, reporting lakhs of infections and hundreds of deaths for the past few weeks. Further, the country's handling of the new wave has been marred by acute shortages of necessary medical equipment such as medical oxygen, hospital beds, ventilators, and drugs. Several friendly nations have rushed essential medical supplies to India in recent days.

Data
India reports 4 lakh cases for third straight day

In the last 24 hours, India reported over four lakh new cases for the third straight day. More than 4,000 deaths linked to the coronavirus were also registered for the first time during the same period. India's active caseload has now crossed 37 lakh. The second wave peak is expected in a few days, however, experts have already warned of a possible third wave.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
India
Defence Research and Development Organisation (DRDO)
Drugs Controller General of India
COVID-19
Related
Latest
Pakistan on toes as Imran Khan leads march to Islamabad
Pakistan on toes as Imran Khan leads march to Islamabad World
Southwest monsoon advancing over Bay of Bengal, Arabian Sea: IMD
Southwest monsoon advancing over Bay of Bengal, Arabian Sea: IMD India
2022 French Open: Novak Djokovic through to third round
2022 French Open: Novak Djokovic through to third round Sports
IPL 2022 Eliminator, RCB's Rajat Patidar slams century: Key stats
IPL 2022 Eliminator, RCB's Rajat Patidar slams century: Key stats Sports
IPL 2022 Eliminator: KL Rahul elects to field
IPL 2022 Eliminator: KL Rahul elects to field Sports
India
Centre reconstitutes Inter-State Council; Modi to be chairman: Details here
Centre reconstitutes Inter-State Council; Modi to be chairman: Details here India
Monkeypox: Maharashtra, Tamil Nadu, Rajasthan prepare to fight against virus
Monkeypox: Maharashtra, Tamil Nadu, Rajasthan prepare to fight against virus India
PM Modi meets Japanese IT giant head, discusses investment opportunities
PM Modi meets Japanese IT giant head, discusses investment opportunities World
Pakistan commits to fighting terrorism, seeks 'balanced ties' with world
Pakistan commits to fighting terrorism, seeks 'balanced ties' with world World
10,000 people stuck as Rishikesh-Yamunotri Highway safety wall collapses
10,000 people stuck as Rishikesh-Yamunotri Highway safety wall collapses India
More News
Defence Research and Development Organisation (DRDO)
Indian Air Force, Navy partner with DRDO for chaff technology
Indian Air Force, Navy partner with DRDO for chaff technology India
DRDO successfully test-fires medium-range surface-to-air missile, destroys target
DRDO successfully test-fires medium-range surface-to-air missile, destroys target India
India flight tests new generation surface-to-air Akash missile
India flight tests new generation surface-to-air Akash missile India
COVID-19 drug 2-DG launched: All you need to know
COVID-19 drug 2-DG launched: All you need to know India
DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered
DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered India
More News
Drugs Controller General of India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory India
More News
COVID-19
COVID-19: India logs 2,124 fresh cases, 17 more deaths
COVID-19: India logs 2,124 fresh cases, 17 more deaths India
COVID-19: India logs 1,675 fresh cases, 31 more deaths
COVID-19: India logs 1,675 fresh cases, 31 more deaths India
Pandemic created a billionaire every 30 hours: Oxfam at Davos
Pandemic created a billionaire every 30 hours: Oxfam at Davos World
First cases of new Omicron subvariants detected in India
First cases of new Omicron subvariants detected in India India
COVID-19 re-emergence: Saudi bans travel to India, 15 other countries
COVID-19 re-emergence: Saudi bans travel to India, 15 other countries World
More News
Related
Shabana Azmi contracts COVID-19; Boney Kapoor leaves quirky comment
Shabana Azmi contracts COVID-19; Boney Kapoor leaves quirky comment Entertainment
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
People are getting COVID-19 at home: Kerala Health Minister
People are getting COVID-19 at home: Kerala Health Minister India
DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022